279 related articles for article (PubMed ID: 12833065)
1. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
[TBL] [Abstract][Full Text] [Related]
2. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.
Berton TR; Mitchell DL; Guo R; Johnson DG
Oncogene; 2005 Apr; 24(15):2449-60. PubMed ID: 15735727
[TBL] [Abstract][Full Text] [Related]
3. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
4. Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1.
Wloga EH; Criniti V; Yamasaki L; Bronson RT
Nat Cell Biol; 2004 Jul; 6(7):565-7; author reply 567-8. PubMed ID: 15232580
[No Abstract] [Full Text] [Related]
5. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
7. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
Pierce AM; Fisher SM; Conti CJ; Johnson DG
Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
9. Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.
Melnikova VO; Pacifico A; Chimenti S; Peris K; Ananthaswamy HN
Oncogene; 2005 Oct; 24(47):7055-63. PubMed ID: 16007135
[TBL] [Abstract][Full Text] [Related]
10. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
11. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53.
Hildesheim J; Bulavin DV; Anver MR; Alvord WG; Hollander MC; Vardanian L; Fornace AJ
Cancer Res; 2002 Dec; 62(24):7305-15. PubMed ID: 12499274
[TBL] [Abstract][Full Text] [Related]
12. Selective DNA damage responses in murine Xpa-/-, Xpc-/- and Csb-/- keratinocyte cultures.
Stout GJ; Oosten Mv; Acherrat FZ; Wit Jd; Vermeij WP; Mullenders LH; Gruijl FR; Backendorf C
DNA Repair (Amst); 2005 Nov; 4(11):1337-44. PubMed ID: 16182614
[TBL] [Abstract][Full Text] [Related]
13. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors.
Cheo DL; Meira LB; Burns DK; Reis AM; Issac T; Friedberg EC
Cancer Res; 2000 Mar; 60(6):1580-4. PubMed ID: 10749126
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
Tomicic MT; Christmann M; Kaina B
Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
[TBL] [Abstract][Full Text] [Related]
16. Topical thymidine dinucleotide application protects against UVB-induced skin cancer in mice with DNA repair gene (Ercc1)-deficient skin.
Lawrence NJ; Song L; Doig J; Ritchie AM; Brownstein DG; Melton DW
DNA Repair (Amst); 2009 May; 8(5):664-71. PubMed ID: 19264557
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of p53 levels in human keratinocytes accelerates Mcl-1 and Bcl-x(L) reduction thereby enhancing UV-light induced apoptosis.
Chaturvedi V; Sitailo LA; Qin JZ; Bodner B; Denning MF; Curry J; Zhang W; Brash D; Nickoloff BJ
Oncogene; 2005 Aug; 24(34):5299-312. PubMed ID: 15940268
[TBL] [Abstract][Full Text] [Related]
18. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
19. EGR-1, a UV-inducible gene in p53(-/-) mouse cells.
Zhang W; Chen S
Exp Cell Res; 2001 May; 266(1):21-30. PubMed ID: 11339821
[TBL] [Abstract][Full Text] [Related]
20. Role of apoptosis in basal cell and squamous cell carcinoma formation.
Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
